Form4insider filings, from the source

SEC Form 3 · accession 0000904454-16-001083

Syndax Pharmaceuticals Inc · SNDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jesse I Treu
10% Owner
James C Blair
10% Owner
Brian H Dovey
10% Owner
Brian K Halak
10% Owner
Kim P. Kamdar
Director · 10% Owner
Nimesh Shah
10% Owner
Period of report
Mar 2, 2016
Accepted (ET)
Mar 2, 2016 · 6:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001395937

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5,F6holding———13,564D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses